|
ZNF606 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.660000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.702200E-01 |
| Normal-vs-Stage2 |
5.605600E-01 |
| Normal-vs-Stage3 |
6.946400E-01 |
| Normal-vs-Stage4 |
1.117440E-01 |
| Stage1-vs-Stage2 |
8.186200E-01 |
| Stage1-vs-Stage3 |
3.291000E-01 |
| Stage1-vs-Stage4 |
2.163700E-02 |
| Stage2-vs-Stage3 |
4.157200E-01 |
| Stage2-vs-Stage4 |
1.249980E-01 |
| Stage3-vs-Stage4 |
3.248400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.836000E-01 |
| Normal-vs-AfricanAmerican |
7.027200E-01 |
| Normal-vs-Asian |
2.065800E-02 |
| Caucasian-vs-AfricanAmerican |
6.350400E-01 |
| Caucasian-vs-Asian |
1.111210E-01 |
| AfricanAmerican-vs-Asian |
1.479220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.932600E-01 |
| Normal-vs-Female |
3.005400E-01 |
| Male-vs-Female |
8.128300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.642800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.548000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.837600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.115000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.113000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.410200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.538000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.158500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.185800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.090200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.695700E-02 |
| Normal-vs-Grade 2 |
3.000200E-02 |
| Normal-vs-Grade 3 |
1.843150E-01 |
| Normal-vs-Grade 4 |
1.179850E-03 |
| Grade 1-vs-Grade 2 |
5.549200E-01 |
| Grade 1-vs-Grade 3 |
5.926100E-02 |
| Grade 1-vs-Grade 4 |
2.400100E-03 |
| Grade 2-vs-Grade 3 |
2.598700E-04 |
| Grade 2-vs-Grade 4 |
2.99149999993809E-07 |
| Grade 3-vs-Grade 4 |
2.292200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.453600E-02 |
| Normal-vs-ccB subtype |
2.672600E-01 |
| ccA subtype-vs-ccB subtype |
1.838490E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.172600E-01 |
| Normal-vs-N1 |
1.263850E-02 |
| N0-vs-N1 |
1.163650E-02 |
|
|
